Trial Details

TERMINATED
Basic Information
Clinical ID c178
Identifier NCT07029971
Trial Title A First-in-Human Study of BB-TL1A-VIAL-HLE in Healthy Adults and People With Ulcerative Colitis
Trial URL Visit Original Page
Study Information
Study Results

NO
Conditions Ulcerative Colitis (UC)
Interventions BIOLOGICAL: BB-TL1A-VIAL-HLE
Participant Information
Sponsor Vial Australia Pty Ltd
City New South Wales
Country/Region Australia
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE1
Time Information
Start Date 2025-06-23
Primary Completion Date 2025-12-23
Completion Date 2025-12-23